Gossamer Bio (GOSS) Reports Q4 Loss, Tops Revenue Estimates
Portfolio Pulse from
Gossamer Bio (GOSS) reported a Q4 loss of $0.15 per share, which was better than the Zacks Consensus Estimate of a $0.17 loss. This is an improvement from the $0.21 loss per share reported a year ago.
March 13, 2025 | 10:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Gossamer Bio reported a Q4 loss of $0.15 per share, beating the Zacks Consensus Estimate of a $0.17 loss. This marks an improvement from the previous year's $0.21 loss per share.
The better-than-expected earnings report and improvement from the previous year suggest positive momentum for Gossamer Bio, likely leading to a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100